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Repeated intramuscular acid injections produce long-lasting mechanical hyperalgesia that depends on activation of ASICs. The
present study investigated if pH-activated currents in sensory neurons innervating muscle were altered in response to repeated
acid injections, and if blockade of ASICs reverses existing hyperalgesia. In muscle sensory neurons, the mean acid-evoked current
amplitudes and the biophysical properties of the ASIC-like currents were unchanged following acidic saline injections when
compared to neutral pH saline injections or uninjected controls. Moreover, increased mechanical sensitivity of the muscle and
paw after the second acid injection was unaﬀected by local blockade of ASICs (A-317567) in the muscle. As a control, electron
microscopic analysis showed that the tibial nerve was undamaged after acid injections. Our previous studies demonstrated that
ASICs are important in the development of hyperalgesia to repeated acid injections. However, the current data suggest that ASICs
are not involved in maintaining hyperalgesia to repeated intramuscular acid injections.
1.Introduction
Acid Sensing Ion Channels (ASICs) are found in peripheral
neuronsandplayasigniﬁcantroleinmodulationofnocicep-
tivebehaviorfollowinginsulttomuscleorjoint.Decreasesin
pHactivateASICs,directlyactivatenociceptors,andproduce
painin humans[1–4].Fourgenesencoding six ASICsubun-
its (ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, ASIC4) have
been identiﬁed. Functional ASICs form as homotrimers or
heterotrimers of three ASIC subunits, and in mouse DRG
neurons the channels primarily exist as heteromers [5, 6].
Of the diﬀerent isoforms, ASIC3 is found predominately in
peripheralsensoryneuronsandhasbeenshowntoplayasig-
nificant role in nociception.
After inﬂammation of the muscle or joint, there is a re-
duction in cutaneous secondary hyperalgesia of the paw in
ASIC3−/− mice and a reduction in primary muscle hy-
peralgesia in ASIC1−/− mice [7–10]. Restoration of ASIC3
expression in primary aﬀerent ﬁbers innervating muscle of
ASIC3−/− mice rescues mechanical hyperalgesia after mus-
cleinﬂammation[7],suggestingasigniﬁcantroleforperiph-
eral ASIC3 in inﬂammatory hyperalgesia from muscle. In
contrast, cutaneous inﬂammatory hyperalgesia is unchanged
or even enhanced in ASIC3−/− mice [11–13]. However, pe-
ripheral blockade of ASIC3 at the time of injection or siRNA
knockdown of ASIC3 in DRG prevents the development of
cutaneous inﬂammatory hyperalgesia in rats [14]. Inﬂam-
mation also induces an increased mRNA (ASIC1 and ASIC3)
and protein expression (ASIC3) in DRG and increased pro-
tein expression in peripheral terminals of nociceptors [8–
10, 15–18]. This enhanced expression in DRG is manifested
asanincreasedresponsiveness toacidicpH[19].Once devel-
oped, inﬂammatory hyperalgesia is reversed by blockade
of ASICs nonselectively, or by selective blockade of ASIC32 Pain Research and Treatment
intrathecally [10, 20, 21]. Together these data suggest an
important role of ASIC1 and ASIC3 in the development and
the maintenance of inﬂammatory musculoskeletal pain.
To model noninﬂammatory chronic muscle pain we de-
veloped a model induced by two injections of acidic saline,
5 days apart, into the gastrocnemius muscle [22]. Like wild-
type mice, ASIC1−/− mice still develop secondary mechani-
cal hyperalgesia of the paw; however, this response was com-
pletelyabrogatedinASIC3−/−mice[23].Inaddition,block-
ade of ASICs during the second acid injection with amiloride
preventsthedevelopmentofsecondaryhyperalgesia24hours
later [23]. These data from our laboratory support that
activation of ASICs, in particular ASIC3, is important for
the development of secondary hyperalgesia in response to
repeated acid injections. However, it is not known if there
are changes in ASICs after the development of hyperalgesia
i nt h i sm o d e l ,o ri fA S I C si nm u s c l ea ﬀerents are important
for maintaining the hyperalgesia. We therefore examined the
properties of ASIC-like currents from retrogradely labeled
muscle sensory neurons, and the eﬀects of antagonism of
ASICs on primary (muscle) and secondary (cutaneous) hy-
peralgesia 24 hours after the second injection of acidic saline.
2.MaterialsandMethods
2.1. Animals. C57BL/6 male mice (age 2–4 months; n58)
(Jackson Laboratories, Bar Harbour, Maine) were used
in these studies. The Animal Care and Use Commit-
tee at the University of Iowa approved all experiments
(ACURF#0908193).
2.2. Labeling of Muscle Sensory Neurons. Sensory neurons
innervating muscle were ﬂuorescently labeled using the
retrograde tracer DiI (1,1-dioctadecyl-3,3,3,3 tetramethylin-
docarbocyanine perchlorate; 17mg/mL dissolved in 20% v/v
ethanol and suspended in 80% v/v sterile saline). Animals
were anesthetized with 2–5% isoﬂurane, a small incision
was made in skin over the left gastrocnemious muscle, and
10μL DiI was injected into the left gastrocnemius muscle as
previously described (n = 30) [18]. After injection, saline-
soaked sterile gauze was placed on the open incision for 10
minutestopreventthedyefromleakingtotheoverlyingskin.
The skin was then sutured closed and mice were allowed to
recover for approximately 2 weeks.
2.3. Intramuscular Acid Injections. For recording experi-
ments, mice were injected 2 weeks after DiI injection into the
same gastrocnemius muscle with 20μLo fp H4 . 0( n = 10)
or pH 7.2 (n = 11) saline while deeply anesthetized with
isoﬂurane (5%). In approximately half the animals a second
20μL of injection of pH 4.0 (n = 6) or pH 7.2 (n = 6) saline
was reinjected into the gastrocnemius muscle 5 days later. 24
hours after a single injection of saline, or 24 hours after a
second injection of saline, mice were euthanized and the L4-
L6 DRG neurons were isolated and cultured. For behavioral
experiments, mice received an initial injection of 20μLo f
pH 4.0 (n = 24) while deeply anesthetized with isoﬂurane
(5%),immediatelyafterbaselinebehavioraltesting.Asecond
injection was repeated 5 days later in all mice.
2.4. Isolation of DRG Neurons. The ipsilateral L4-L6 DRGs
were collected and dissociated as previously described [6].
DRGs were treated with papain and collagenase/dispase and
thengentlytrituratedtoisolateneurons.Neuronsuspensions
were then plated on 35mm Petri dishes coated with poly
L-lysine and laminin. Cells were cultured in F12 medium
supplemented with 10% heat inactivated serum, penicillin-
streptomycin, and 50ng/mL NGF. 24 hours after plating we
examined cells with whole-cell patch-clamp.
2.5. Electrophysiology of Cultured DRG Neurons. Whole-cell
patch-clamp recordings of DiI labeled DRG neurons were
performed at room temperature at a holding potential of
−70mV. Currents were ﬁltered at 1kHz and sampled at
2kHz using the Axopatch 200B ampliﬁer, Digidata 1200,
and Clampex 8.2 (Axon instruments, Union city, CA). Mi-
cropipettes (3–5MΩ) were ﬁlled with internal solution
(mM): 100 KCl, 10 EGTA, 40 Hepes, 5 MgCl2,p H7 . 4
with KOH. External solutions contained (mM) 120 NaCl,
5 KCl, 1 MgCl2,2C a C l 2, 10 HEPES, and 10 MES; pH was
adjusted with tetramethylammonium hydroxide; osmolarity
was adjusted with tetramethylammonium chloride. Extra-
cellular pH solutions ((pH 7.4 (control)), 6.8, 6.5, 6.0, 5.0)
wereusedtostudyASICcurrents.Wholecellcapacitancewas
compensated and recorded. Solutions with diﬀerent pH were
applied directly to the cell by using a perfusion system BPS
8 (ALA scientiﬁc, Westbury NY), which was controlled by
Digidata 1200 and Clampex 8 software (pClamp8).
To measure pH dose responses, pH currents activated
by pH 5, 6, 6.5, and 6.8 solutions were normalized to pH
5 induced currents. Time constants for desensitization were
measured from single exponential ﬁt to the falling phase of
the current evoked by pH application. The time course of
recovery from desensitization was measured by completely
desensitizingtheASICcurrentatpH6byalongdesensitizing
pulse followed by bathing in pH 7.4 for a deﬁned time
followed by a second stimulation at pH 6. Recovery is per-
centageof recoveryof current evoked by second pulse by ﬁrst
pulse.
2.6. Behavioral Assessment. Mice were given one dose of
0.025μmol A-317567 (C-(6-[2-(1-isopropyl-2-methyl-1,2,
3,4-tetrahydro-isoquinolin-7-yl)-cyclopropyl]-naphthalen-
2-yl)-methanediamine) (10μL) injected into the left gas-
trocnemius muscle 24 hours after induction of hyperalgesia.
This dose was based on our prior study which showed a
reduction in pain-behaviors after muscle inﬂammation [10].
Separate mice were used to test behavioral sensitivity. Muscle
sensitivity was tested as follows: before the ﬁrst injection
of the muscle, before the second injection of the muscle,
24 hours after the second injection, and 15 minutes after
A-317567 injection. A-317567 was injected intramuscularly
immediately after the 24 hours behavioral test. C57BL/6
mice were acclimated for 2 days before testing for muscle
sensitivityandcutaneousmechanicalsensitivity,asdescribedPain Research and Treatment 3
previously [8] and separate groups of mice were used to
test muscle sensitivity and cutaneous sensitivity. Muscle me-
chanicalsensitivity wastestedbysqueezingthegastrocnemius
muscle of the mice witha calibratedpair of tweezersuntil the
mouse withdrew from the stimulus as previously described
[10]. The force at which the mouse withdrew was measured
in mN. A decrease in threshold was interpreted as muscle
hyperalgesia. Cutaneous mechanical sensitivity was tested
bilaterally by assessing the number of responses to repeated
application of a 0.4 mN von Frey ﬁlament to the plantar
surface of the paw as previously described [23]. The number
of withdrawals out of 5 was assessed in 10 trials and an
average of all 10 trials was determined for each time period.
A signiﬁcant increase in the number of responses was in-
terpreted as cutaneous hyperalgesia.
2.7. Electron Microscopy. Twenty-four hours after injection
of acidic saline, mice were deeply anesthetized sodium pen-
tobarbital (60mg/kg, i.p.) and transcardially perfused with
2.5% gluteraldehyde in 0.1M cacodylate buﬀer. The tibial
nerve was dissected bilaterallyand placed in the same ﬁxative
until processing. Post ﬁxation was carried out for 1 hour
at room temperature with a buﬀered 1% osmium tetroxide
solutionreducedwith1.5%potassiumferrocyanide.Samples
were stained with 2.5% uranyl acetate. Blocks were then
rinsed and dehydrated using gradually increasing concen-
trations of acetone to 100%. Inﬁltration of Spurr’s epoxy
resin and acetone were carried out over several days to 100%
resin and cured 48 hours in a 60◦C oven. Sections of 100nm
thickness were cut using a Leica UC-6 ultramicrotome and
collected on 400 mesh copper grids. The grids were then
counterstained with 5% uranyl acetate for 2 minutes and
Reynold’s lead citrate for 2 minutes. Samples were imaged
using a JEOL 1230 transmission electron microscope at
120KV.
2.8. Experimental Design. Experiment 1 tested pH currents
in DRG isolated from ﬁve groups of mice were used for the
present study as follows: a control group that did not receive
injections into the gastrocnemius muscle (n = 9m i c e ;5 7
cells),acontrolgroupinjectedwithpH7.2salineonce(n = 5
mice, 28 cells), an experimental group injected with pH 4.0
saline once (n = 4 mice, 22 cells), a control group injected
with pH 7.2 saline twice (n = 6 mice, n-48 cells), and an
experimental group injected with pH 4.0 saline twice (n = 6
mice, 41 cells).
Experiment2testedtheeﬀectsofblockadeofASICchan-
nels, with A-317567, after the development of hyperalgesia.
We tested the responses in two separate groups of animals.
O n eg r o u pw a st e s t e df o rp a ws e n s i t i v i t y( n = 6 A-317567,
n = 6 vehicle) and one for muscle sensitivity (n = 6A -
317567, n = 6 vehicle). A-317567 was tested against a vehicle
control with the tester blinded to drug or vehicle injection.
Experiment 3 tested if pH 4.0 saline produced nerve
damage using electron microscopy in 2 mice per group 24
hours after injections as follows: (1) pH 4.0, single injection,
(2)pH7.2,singleinjection, (3)pH4.0twoinjections, (4)pH
7.2 two injections.
2.9. Statistical Analysis. Patch clamp data were analyzed
using Clampﬁt (Axon instruments), Microsoft Excel, and
Origin 7 software (Northampton MA). A two-way ANOVA
was used to study diﬀerences between groups and diﬀerences
between pH using SPSS 17. Post hoc testing between groups
was performed with a Tukey’s test. P<0.05 was considered
signiﬁcant. Behavioral data were analyzed with a repeated
measures ANOVA for diﬀerences across time and between
g r o u p s .D a t aa r er e p r e s e n t e da sm e a n± SEM.
3. Results
3.1. Injection of pH 4.0 Does Not Alter the Number of DRG
Neurons Expressing ASIC-Like Currents. To test if ASICs
current properties were altered after repeated acid injections,
we performed whole-cell patch clamp of retrogradely labeled
muscle aﬀerents 24 hours after the second acid injection.
Figure 1(a) shows representative traces of proton-activated
currentsrecordedfromalabeledmuscleDRGneuron.Acidic
pH evoked a rapidly activating transient current that then
desensitized in the continued presence of acid. In some
neurons pH 5 and pH 6 activated currents had a sustained
current along with a transient component. The transient
component properties are characteristic of ASICs [6, 22],
whereas the sustained component can also represent acti-
vation of transient receptor potential subfamily vanilloid
1 (TRPV1) channels in DRG neurons [24]. We previously
demonstrated that the transient component of pH-activated
currents in muscle DRG neurons was blocked by the ASIC
inhibitor, amiloride, and was unaﬀected by the TRPV1 in-
hibitor, capsazepine [18]. Therefore, we deﬁned a neuron as
expressing an ASIC-like current if pH 5 evoked a transient
inward current of greater than 100pA. We compared the 5
groups of mice (uninjected, one or two injections of pH 7.2
or 4.0) and found no statistical diﬀerence in the percentage
of labeled muscle aﬀerents that expressed ASIC-like currents
(Figure 1(b)). Thus, intramuscular acid injections do not
appeartoalterthepercentageofmuscleaﬀerentsthatexpress
ASICs.
ASICsareexpressedinsmall-andmedium-sizedneurons
that can respond to noxious stimuli and are also expressed in
larger neurons that correspond to low threshold mechanore-
ceptors [25]. Muscle sensory neurons that possessed ASIC-
like currents were medium-size-neurons, and neurons that
did not express ASIC-like currents were signiﬁcantly smaller
(Figure 1(c))( F1,195 = 11.2, P = 0.001; sizes ranged in both
groups from 20 to 37μm). Furthermore, there was no differ-
ence in cell sizes between treatment groups, suggesting that
intramuscular acid injection did not cause a shift in ASIC
expression in neurons of a particular size.
3.2. Mean Current Amplitudes of pH-Evoked Currents Are
Unchanged after Intramuscular Injection of Acid. We next
examined if there were increases in ASIC expression after
inﬂammation by examining the amplitude of current in re-
sponse to acidic pH. There was no signiﬁcant diﬀerence be-
tween groups for the current amplitude. Twenty-four hours
after the ﬁrst acid injection the mean maximal current4 Pain Research and Treatment
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Figure 1: (a) Representative traces of pH currents recorded in DRG neurons innervating muscle. (b) The percentage of labeled muscle
DRG neurons that responded to pH 5 application with a transient inward current (ASIC-like current) greater than 100pA is shown for each
experimental group. (c) The mean cell diameters of the muscle DRG neurons that responded to pH 5 application with a transient ASIC-like
current(responders;blackbars)arecomparedtothosethatdidnotrespond(nonresponders;openbars)foreachoftheexperimentalgroups.
The number of responders in each group is as follows: uninjected = 29/57; Injection 1, pH 7.2 = 19/29; Injection 1, pH 4.0 = 22/35; Injection
2, pH 7.2 = 25/48; Injection 2, pH 4.0 = 24/36.
∗P < 0.05.
amplitude was 1904 ± 446pA (n = 22) (Figure 2(a))a n d
similar to that after the second acid injection (1521 ± 305,
n = 24), or pH 7.2 injected controls (Injection 1: 2808 ±
474, n = 19; Injection 2: 2856 ± 376, n = 25), or uninjected
(2228 ± 338, n = 28) controls.
3.3. ASIC Channel Properties Were Unaltered by Intramus-
cular Acid Injections. Sensory neurons have been found to
express ASIC1, ASIC2, and ASIC3 isoforms and generally
form as heteromers in mouse DRG neurons [6], and each of
the diﬀerent heteromeric combinations of channels displays
diﬀerent biophysical properties [6, 26]. To determine the
relative distribution of isoforms we studied diﬀerent proper-
ties of ASIC currents including pH sensitivity of activation,
desensitization kinetics, and recovery from desensitization.
We hypothesized that hyperalgesia associated with intramus-
cular acid injections might cause a change in the subunit
composition of the ASIC channels, and we could detect
this as a change in the biophysical properties. Figure 2(b)
shows that the pH sensitivity of ASIC currents, measured
by normalizing the current amplitude recorded at varying
pH (6.8–6.0) to the pH 5 current amplitude, did not
change signiﬁcantly after intramuscular acid injections when
compared to uninjected and pH 7.2 injected controls.
ASIC currents desensitize in the continued presence of
acidic pH. By ﬁtting the desensitizing phase of the currents
to single exponentials, the rates of desensitization (τ)w e r e
measured. Figure 3(a) demonstrates that intramuscular acid
injections did not change the rate of desensitization of the
ASIC-like currents compared to control groups injected with
pH 7.2 or uninjected controls.
After ASIC channels desensitize, they need to be exposed
again to a more alkaline pH for some period of time to allow
the channels to “recover”, before they can be activated again
(see methods for protocol of how recovery was measured).
Figure 3(b) shows that the intramuscular acid injections
did not alter the rate of recovery from desensitization. In
summary, we found no change in the distribution of muscle
DRG neurons that expressed ASIC-like currents, nor were
there changes in the current properties at either 24 hours
after the ﬁrst or 24 hours after the second injection of acidic
saline.Pain Research and Treatment 5
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Figure 2: (a) The mean current amplitudes of pH currents at pH
5, 6, 6.5, and 6.8 are not signiﬁcantly diﬀerent between groups
injected with pH 4.0 (Injection 1, n = 22; Injection 2, n = 24)
and controls injected with pH 7.2 (Injection 1, n = 19; Injection
2, n = 25), or uninjected controls (n = 28). (b) Data from (2A)
was normalized to the peak transient currents evoked by pH 5
to analyze pH dose responses. pH dose responses and were not
diﬀerent between groups injection with pH 4.0 (Injection 1, n = 21;
Injection 2, n = 24) and those injected with pH 7.2 (Injection 1,
n = 19; Injection 2, n = 24) or uninjected controls (n = 27).
3.4. Muscle and Cutaneous Hyperalgesia Is Unaﬀected by
Intramuscular Blockade of ASICs with A-317567. Our pre-
vious work demonstrated that ASICs are required for the
development of secondary hyperalgesia of the paw after
repeated intramuscular acid injections [23]. Here we tested
if continued activation of ASICs was necessary to maintain
the hyperalgesia after it had been developed. As previously
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Figure 3: (a) The mean time constants of desensitization of ASIC-
like transient currents evoked by the indicated pH solutions were
similar between uninjected (n = 26), controls injected with pH 7.2
(Injection 1, n = 18 Injection 2, n = 22) and those injected with
pH 4.0 (Injection 1, n = 19; Injection 2, n = 21). (b) The rate of
recovery from desensitization is similar between groups: uninjected
(n = 12),controlsinjectedwithpH7.2(Injection1,n = 3;Injection
2, n = 15) and those injected with pH 4.0 (Injection 1, n = 7;
Injection 2, n = 10).
shown, repeated intramuscular injection of pH 4.0 saline
increases the number of responses of the paw to repeated
stimulation (Figure 4(a)) and decreases the force threshold
to withdrawal of the muscle (Figure 4(b)), 24 hours after
thesecondinjection.Interestingly,intramuscularinjectionof
0.025μmol of A-317567, a dose previously shown to reverse
musclecutaneoussensitivityaftermuscleinﬂammation[10],6 Pain Research and Treatment
0
0.5
1
1.5
2
2.5
3
Inj 1 Inj 2 Drug
R
e
s
p
o
n
s
e
s
(
0
-
5
)
Vehicle, ipsi (n = 6)
A-317567, ipsi (n = 6)
Vehicle, contra (n = 6)
A-317567, contra (n = 6)
24h
(a)
T
h
r
e
s
h
o
l
d
(
m
N
)
1000
1200
1400
1600
1800
2000
2200
Inj 1 Inj 2 24h Drug
Vehicle, ipsi (n = 6)
A-317567, ipsi (n = 6)
Vehicle, contra (n = 6)
A-317567, contra (n = 6)
(b)
Figure 4: ASIC pharmacological antagonism has no eﬀect upon
primary (muscle) or secondary (cutaneous) hyperalgesia induced
by repeated intramuscular acid injections. (a) Mean muscle with-
drawal thresholds. (b) mean number of responses to repeated von
Frey stimulation of the paw measured before ﬁrst and second acid
injections, 24 hours after second acid injection, and after intramus-
cular injection of A-317567 or control injection. While there was
an increase in mechanical sensitivity of the paw and muscle after
repeated acid injections, there was no diﬀerence in this sensitivity
after intramuscular injection of the ASIC antagonist.
had no eﬀect on the enhanced cutaneous and muscle sensi-
tivity induced by repeated acid injections (Figures 4(a) and
4(b)).
3.5.RepeatedAcidInjectionsDoNotProduceDamagetoTibial
Nerve. Tobecertainthatrepeatedacidinjectionsdonotpro-
ducedamagetothetibialnerve,andhencecauseneuropathic
pain, we performed electromicrographic analysis of the tibial
nerve after injections of pH 4.0 compared to the tibial nerves
from the contralateral hindlimb. As shown in Figure 5, there
was no diﬀerence between the muscles injected with pH 4.0
and those injected with pH 7.2, or from the contralateral
hindlimb. This was observed 24 hours after a single injection
of pH 4.0 or 24 hours after the second injection of pH 4.0.
4. Discussion
We previously found that ASICs are necessary for the devel-
opment of hyperalgesia after repeated intramuscular acid
injection [23]. The current study shows that ASICs are not
involved in maintaining the hyperalgesia once it has already
developed. We found that pharmacological inhibition of
ASICs 24 hours after a second intramuscular acid injection,
at a time when hyperalgesia is well established, had no
eﬀect upon muscle or cutaneous hyperalgesia. Moreover, we
found that repeated acid injections produced no change in
the expression of ASIC-like currents or their properties in
labeled muscle DRG neurons, suggesting that hyperalgesia in
thismodelisnotassociatedwithchangesinASICexpression.
Prior studies from our laboratory show that ASIC3 is
important for the induction of long-lasting mechanical hy-
peralgesia of the paw after repeated acid injections [23].
Speciﬁcally, ASIC3−/− mice do not develop mechanical hy-
peralgesia of the paw after repeated acid injections when
compared to ASIC3+/+ mice [23]. Further, nonselective
inhibition of ASICs, or selective blockade of ASIC3, given at
the time of the second acid injection prevents the onset of
hyperalgesia 24 hours later [23, 27]. This lack of hyperalgesia
in ASIC3−/− mice is likely the result of a loss of central sen-
sitization. Recordings from dorsal horn neurons show that
ASIC3−/− mice do not show enhanced responsiveness to
mechanicalstimulationorexpansionofreceptiveﬁelds,mea-
sures of central sensitization, when compared to ASIC3+/+
mice [23]. These data, therefore suggest that ASIC3 is im-
portant in the induction of long-lasting hyperalgesia and
central sensitization.
This noninﬂammatory pain model is unique and, once
developed, likely depends on central mechanisms. Prior
studies from our laboratory and others show that pharmaco-
logically NSAIDs are ineﬀective while channel blockers and
agents with central actions, opioids and pregabalin, reverse
the hyperalgesia once developed [28–30]. After the second
acid injection, we show that receptive ﬁelds of dorsal horn
neurons expand to include the contralateral hindlimb, there
is increased mechanical sensitivity of the paw bilaterally
[23] and Miranda et al., show increased visceral sensitivity
[31], all indicative of central changes. Mechanistically, we
show an increase in glutamate release both spinally and su-
paspinally in response to the second, but not the ﬁrst, intra-
muscularacidinjection[32,33].Similarly,weshowthatlocal
anesthetic blockade at the level of the rostral ventromedial
medulla during the second, but not the ﬁrst, acid injection
preventsthedevelopmentofhyperaglesia24hourslater[34].
Together, these data suggest that induction of the hyperalge-
sia initially involves activation of ASICs in muscle aﬀerents,
that then send input to the central nervous system to result
in enhanced excitability both spinally and supraspinally.Pain Research and Treatment 7
Contralateral
I
n
j
e
c
t
i
o
n
1
(a)
Ipsilateral
0.5µm
(b)
I
n
j
e
c
t
i
o
n
2
1µm
(c)
0.5µm
(d)
Figure 5: Electron micrograph showing the tibial nerve ipsilateral and contralateral to the site of injection of pH 4.0 saline. The tibial nerve
was examined 24 hours after the ﬁrst injection and 24 hours after the second injection for potential structural changes and inﬂammatory
cell inﬁltration. There were no observable changes at either time point when compared to the contralateral hindlimb after repeated acid
injections.
Oncethehyperalgesiadevelops,however,localanesthetic
or neurotrophin-3 delivered directly to the muscle has no
eﬀect [22, 35] suggesting that peripheral mechanisms do not
maintain the hyperalgesia. Our data are consistent with the
conclusion that peripheral mechanisms do not maintain the
hyperalgesia since blockade of ASICs did not aﬀect the ongo-
ing hyperalgesia. Similarly, the selective ASIC3 antagonist
APETx2 also has no eﬀect on the hyperalgesia in this model
once developed [27]. On the other hand, our laboratory
showedthatlocalanestheticblockadesupraspinallyorblock-
ade of NMDA receptors spinally and supraspinally reverses
the hyperalgesia once developed [34, 36, 37]. This activation
ofNMDAreceptorslikelyturnsonsecondmessengersystems
to result in long-lasting sensitivity and hyperalgesia. In sup-
port we show an increase in phosphorylation of the tran-
scription factor CREB and blockade of the cAMP pathway
reversesthehyperalgesiaoncedeveloped[38].Thus,oncethe
hyperalgesia develops in the noninﬂammatory muscle pain
model, there are no changes in the number or sensitivity
of ASICs and blockade of ASICs has no eﬀect on hyperal-
gesia.
In contrast inﬂammatory muscle pain clearly involves
activation of ASICs for the maintenance of the hyperalgesia.
Speciﬁcally, we show that pharmacological blockade of
ASICswiththenonselectiveantagonistA-317567reversesthe
hyperalgesia once developed [10]. In both muscle and paw
inﬂammation models, we and others show an increase in the
amplitude of pH responsiveness of DRG and an increase in
mRNA for ASICs [10, 14]. Our laboratory also showed an
increase in the number of joint aﬀerents that express ASIC3
after joint inﬂammation [8]. This suggests that mechanisms
underlying the maintenance of muscle inﬂammatory pain
are uniquely diﬀerent from those underlying the mainte-
nance of noninﬂammatory muscle pain.8 Pain Research and Treatment
The hyperalgesia associated with the muscle is processed
diﬀerently from that associated with the skin. For ASICs
there is a greater expression of ASIC3 in small DRG neu-
rons innervating muscle when compared to DRG neurons
innervating skin [39]. In this noninﬂammatory model, fos
expression in response to the muscle stimulation after the
development of hyperalgesia increased in the superﬁcial dor-
sal horn compared to controls and was increased after paw
stimulation in acid-injected WT but not acid-injected NT-
3 muscle-speciﬁc knockouts or NT-3 muscle-injected mice
[35, 40]. The lack of injury to the tibial nerve shown in
the current study after repeated acid injections is consistent
with the fact that there is no peripheral tissue damage or
inﬂammation in response to repeated acid injections [22].
Thus, the muscle hyperalgesia at the site of acid injection
and in the contralateral muscle can be considered secondary
hyperalgesia. Without peripheral damage to the nerve inner-
vating the paw, we further conclude that the hyperalgesia of
the paw is also secondary hyperalgesia.
Itisunclearhowrepeatedinjectionsofacidicsalineresult
in widespread hyperalgesia after the second but not the ﬁrst
injection. In addition to muscle and cutaneous hyperalgesia,
this model is also associated with enhanced visceral hyper-
algesia [31]. The widespread nature of the hyperalgesia sug-
gests involvement in the central nervous system. Peles et al.
show that a single injection of pH 4.0 saline enhances spon-
taneous ﬁring of spinal neurons as well as the response to
colorectal distension [41]. It is possible that this sensitization
lastsforseveraldayssettingupthenervoussystemtorespond
in an exaggerated manner to the second acid injection. In-
deed both spinally and supraspinally there is enhanced glu-
tamate release during the second acid injection [32, 33]
and sensitization of dorsal horn neurons in response to the
second acid injection [23]. The increased glutamate at the
spinallevelisclearlyimportantinthedevelopmentofthehy-
peralgesia as spinal blockade of NMDA receptors during the
second acid injection delays the onset of hyperalgesia [36].
Thus, the central sensitization induced by peripheral acid
injections likely underlies the widespread nature of the hy-
peralgesiainducedbythismodel.ActivationofASICs,inpar-
ticular ASIC3, plays a critical role in the development of this
centralsensitization,whichisabsentinASIC3−/−mice[23].
5. Conclusion
In summary, the current study shows that once developed
the hyperalgesia associated with repeated acid injection does
not depend on continued activation of ASICs. There are
no changes in expression of ASIC channels in terms of the
number or subunit composition and blockade of ASICs after
development of hyperalgesia is ineﬀective. These data fur-
ther support existing studies showing that the hyperalgesia
induced by repeated acid injections is maintained by central
mechanisms.
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